
Sign up to save your podcasts
Or


In Oregon and Colorado, you can book an appointment for psilocybin therapy, where a licensed therapist takes you on a guided trip using the drug that makes “magic” mushrooms hallucinogenic.
Under federal law, psilocybin is illegal. But within the past few years, both states greenlit the drug for supervised medical use, and New Mexico may soon follow. It’s being used to treat certain conditions, including drug-resistant depression and PTSD. With a lot more people taking the drug under state supervision, what are we learning about its safety and efficacy? Who is taking it, and can clinics make money?
Host Flora Lichtman checks in on the state of these programs with Colorado Public Radio journalist Alejandro Galva. Then, she sits down with geriatric and palliative care specialist Stacy Fischer for a research update on the therapeutic use of the drug, and the nation’s largest clinical trial for psilocybin use for advanced cancer patients facing mental health challenges.
Guests:
Alejandro Galva is the afternoon editor at Colorado Public Radio. He’s also the editor of their series “The Trip,” which covers the psychedelic therapy landscape in the state.
Dr. Stacy Fischer is a geriatric and palliative care specialist at UCHealth University of Colorado Hospital.
Transcripts for each episode are available within 1-3 days at sciencefriday.com.
Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.
By Science Friday and WNYC Studios4.4
60206,020 ratings
In Oregon and Colorado, you can book an appointment for psilocybin therapy, where a licensed therapist takes you on a guided trip using the drug that makes “magic” mushrooms hallucinogenic.
Under federal law, psilocybin is illegal. But within the past few years, both states greenlit the drug for supervised medical use, and New Mexico may soon follow. It’s being used to treat certain conditions, including drug-resistant depression and PTSD. With a lot more people taking the drug under state supervision, what are we learning about its safety and efficacy? Who is taking it, and can clinics make money?
Host Flora Lichtman checks in on the state of these programs with Colorado Public Radio journalist Alejandro Galva. Then, she sits down with geriatric and palliative care specialist Stacy Fischer for a research update on the therapeutic use of the drug, and the nation’s largest clinical trial for psilocybin use for advanced cancer patients facing mental health challenges.
Guests:
Alejandro Galva is the afternoon editor at Colorado Public Radio. He’s also the editor of their series “The Trip,” which covers the psychedelic therapy landscape in the state.
Dr. Stacy Fischer is a geriatric and palliative care specialist at UCHealth University of Colorado Hospital.
Transcripts for each episode are available within 1-3 days at sciencefriday.com.
Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

91,297 Listeners

21,954 Listeners

43,837 Listeners

32,246 Listeners

38,430 Listeners

30,609 Listeners

43,687 Listeners

38,950 Listeners

1,576 Listeners

484 Listeners

945 Listeners

12,704 Listeners

14,450 Listeners

12,130 Listeners

818 Listeners

1,542 Listeners

3,506 Listeners

2,800 Listeners

1,405 Listeners

9,556 Listeners

1,196 Listeners

5,569 Listeners

5,767 Listeners

421 Listeners

16,512 Listeners

6,592 Listeners

670 Listeners

2,821 Listeners

2,303 Listeners

644 Listeners

1,965 Listeners

82 Listeners

246 Listeners

20 Listeners